Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 273 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q3
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $80,000.00 income
Health Issues, Taxation/Internal Revenue Code
View →
Q3
NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES for NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Education, Health Issues, Medicare/Medicaid, Defense
View →
Q3
MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q3
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q3
ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate
Medicare/Medicaid, Health Issues, Tobacco, Budget/Appropriations
View →
Q3
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid
View →
Q3
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q3
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate
Health Issues
View →
Q3
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Pharmacy, Trade (domestic/foreign)
View →
Q3
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Defense
View →
Q3
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q3
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q3
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q3
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q2
YC CONSULTING, LLC for PATIENTS RISING NOW
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues
View →
Q2
ALLIANCE FOR REGENERATIVE MEDICINE for ALLIANCE FOR REGENERATIVE MEDICINE
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q2
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q2
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate
Health Issues, Insurance, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q2
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Taxation/Internal Revenue Code
View →
Q2
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues
View →
Q2
SPLITOAK STRATEGIES LLC for CHIESI USA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · North Carolina · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Agriculture
View →
Q2
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Agriculture, Animals, Budget/Appropriations
View →
Previous Page 8 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem